My Account | Shopping Cart | Contact
Trilink Biotech Logo

Oligonucleotides | mRNA & Long RNA | Nucleotides | CleanCap™ | CleanTag™ | CleanAmp™ | Custom Chemistry | GMP

Resources

FAQs: Ask An Expert
Technical Articles
Bibliography
Literature Corner
eNewsletters
Blog: Zone in With Zon
TriLink Publications
Related Services
Research Updates

 

Literature Corner

Electronic copies of our brochures and posters can be downloaded by clicking the links below.

Brochures
Oligo NTP Brochure CleanAmp RNA StartUp
Oligonucleotides Modified Nucleotides CleanAmp™ PCR Products mRNA & Long
RNA
Start-Up & Emerging Companies

Posters
Pushing the Limits of Small RNA-Seq with Chemically Modified Adapters Modified Messenger RNA
Improving NGS Small RNA Discovery in Biological Fluids and Other Low-Input Samples

Reaction Conditions
Nucleotide Modifications for Improved Messenger RNA Expression

Pushing the Limits of Small RNA-Seq with Chemically Modified Adapters

Reaction Conditions
The Universal Hot Start Tool: CleanAmp™ Hot Start dNTPs

Reaction Conditions
Making the Optimal Messenger RNA for Gene Therapy Applications:
Hot Start Ligase Chain Reaction Use of mitoPrimers™ and CleanAmp™ PCR Master Mix for Mitochondrial DNA Testing Gene Expression from Pseudouridine and 5-Methylcytidine Modified Messenger RNA Gene Expression from Pseudouridine and 5-Methylcytidine Modified Messenger RNA Using UNA Substitions
Hot Start Activation of DNA Ligase Chain Reaction Using CleanAmp™ Primers Use of mitoPrimers™ and CleanAmp™ PCR Master Mix for Mitochondrial DNA Testing Generating Optimal Pseudouridine and 5-Methylcytidine Modified Messenger RNA for iPS Cell Reprogramming Improved Ligation Specificity with Chemically Modified Ligation Components Using Unlocked Nucleic Acid (UNA) Substitutions to Alter Strand Selection by the RNA Induced Silencing Complex
dGTP Primer Litigation Primer Multiplex Poster
CleanAmp™ Hot Start 7-deaza-dGTP for Improved GC-rich PCR Amplification Chemically Modified Primers for PCR
and Ligation Applications
Chemically Modified Primers for Improved Multiplex PCR Improved MicroRNA Library Preparation Workflow for Next-Generation Sequencing

Reaction Conditions
Ultra-Low RNA Inputs Result in High Quality Small RNA-Seq Data

Reaction Conditions
HPLC Purified Wild-type Cap1 EGFP mRNAs Perform as Well as Pseudouridine Modified mRNAs in Cultured Cells(TIDES) Development of Standardized Pathogen Detection Assays Using CleanAmp? Master Mixes (Mol DX)

Reaction Conditions
Advances in Small RNA NGS; Low Input Samples and Automation (GTC NGS)

Reaction Conditions
Small RNA Library Preparation from Single Cell Quantities and Low Input Biological Samples(Exosomes & Micorvesicles)

Reaction Conditions
N1-Modified Pseudouridine 5?-Triphosphates for Transcription and Translation of Messenger RNA(IRT)
HPLC Purified WT Cap1 EGFP mRNAs Perform as Well as PseudoU Modified mRNAs in Cultured Cells(IRT) Maximizing the Translation and Activity of mRNA Therapeutics(Translational Control) Improved MicroRNA Library Preparation Workflow for NGS Allows Ultra-Low Inputs and Eliminates Gel Purification(OTS 2016) HPLC Purified Wild-type Cap1 EGFP mRNAs Perform as Well as Pseudouridine Modified mRNAs in Cultured Cells(OTS 2016) Improved Small RNA Library Preparation for Ultra-Low Input Sample Types (NGS,SCA,SMA & Mass Spec)
Improved Small RNA Sequencing for Low Input Samples(ASMEV)

Reaction Conditions
Advances in Small RNA NGS; Low Input Samples and Automation (ASHG 2016)

Reaction Conditions
Development of Standardized Pathogen Detection Assays Using CleanAmp™ Master Mixes (ASHG 2016)

Reaction Conditions
Maximizing Translation of mRNA Therapeutics By Sequence Engineering and Chemical Modification (mRNA Health 2016) Maximizing Translation of mRNA Therapeutics
(RNA Editing 2017 GRC)
Innate Immune Focused Approaches to Maximize Messenger RNA Therapeutic Activity (Pattern Recognition Signaling: 2017 Keystone)

Considerations for the Design and cGMP Manufacturing of mRNA Therapeutics (TIDES 2017) Maximizing Translation of Cas9 mRNA Therapeutics by Sequence Engineering and Chemical Modification (ASGCT 2017) Utilizing Human Whole Blood to Predict In Vivo Immune Responses Against In Vitro Transcribed Chemically Modified Cas9 mRNA(ASGCT 2017) Novel N1-Substituted Pseudouridine 5-Triphosphates for the Synthesis of Modified mRNA and its Effect on mRNA Translation in THP-1 cells (SCNAC 2017)
Maximizing Translation of mRNA Therapeutics By Sequence Engineering and Chemical Modification( 7th Cambridge Symposium on Nucleic Acids Chemistry & Biology 2017)

Exploring the Epitranscriptome: Properly Capped and Chemically Modified Cas9 mRNAs For Genome Editing as a Case Study (1st Nucleic Acid Modifications 2017) Considerations for the Design and cGMP Manufacturing of mRNA Therapeutics
(OTS 2017)
Innate Immune Focused Approaches to Maximize Messenger RNA Therapeutic Activity
(OTS 2017)
Electrokinetic Microfluidic Chip and Chemically Modified Adapters Streamline Single-Cell Next-Generation Sequencing of Small Non-coding RNA
(RNA-Seq, Single Cell Analysis & Single Molecule Analysis 2017 )
Preparing Small RNA Libraries from Low Input and Single Cell Total RNA (ASHG 2017)

Innate Immune Focused Approaches to Maximize Messenger RNA Therapeutic Activity (DIA Oligo Therapeutics 2017)

CleanCap Allows Diverse 5 Cap Modifications: The New Frontier of the RNA Epitranscriptome (mRNA Health 2017)

 

  Twitter Twitter Facebook Facebook Linked In Linked In RSS RSS Google RSS  
© 2017 TriLink BioTechnologies, LLC | All Rights Reserved